Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators.

tofacitinib - Generic mfg.

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Zeposia (ozanimod) - BMS

Velsipity (etrasimod) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42704602

Fatma Karapinar-Çarkit; Luc J J Derijks; Marieke J Pierik; Rob J van Marum

Sep 8, 2026